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Abstract 
Background:  Cerebral malaria (CM) is a life-threatening disease, caused mainly by Plasmodium falciparum in 
humans. In adults only 1–2 % of P. falciparum-infected hosts transit to the cerebral form of the disease while most 
exhibit non-cerebral malaria (NCM). The perturbed metabolic pathways of CM and NCM have been reported. Early 
marker(s) of CM is(are) not known and by the time a patient exhibits the pathological symptoms of CM, the disease 
has progressed. Murine CM, like the human disease, is difficult to assign to specific animals at early stage and hence 
the challenge to treat CM at pre-clinical stage of the disease. This is the first report of prediction of CM in mice using a 
novel strategy based on 1H nuclear magnetic resonance (NMR)-based metabolomics.
Methods: Mice were infected with malarial parasites, and serum was collected from all the animals (CM/NCM) before 
CM symptoms were apparent. The assignment of mice as NCM/CM at an early time point is based on their symptoms 
at days 8–9 post-infection (pi). The serum samples were subjected to 1H NMR-based metabolomics. 1H NMR spectra of 
the serum samples, collected at various time points (pi) in multiple sets of experiments, were subjected to multivari-
ate analyses.
Results: The results from orthogonal partial least square discriminant analyses (OPLS-DA) suggest that the animals 
with CM start to diverge out in metabolic profile and were distinct on day 4 pi, although by physical observation they 
were indistinguishable from the NCM. The metabolites that appeared to contribute to this distinction were serum 
lipids and lipoproteins, and 14–19 % enhancement was observed in mice afflicted with CM. A cut-off of 14 % change 
of total lipoproteins in serum predicts 54–71 % CM in different experiments at day 4 pi.
Conclusion: This study clearly demonstrates the possibility of differentiating and identifying animals with CM at an 
early, pre-clinical stage. The strategy, based on metabolite profile of serum, tested with different batches of animals 
in both the sex and across different times of the year, is found to be robust. This is the first such study of pre-clinical 
prognosis of CM.
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Background
Pathological manifestations of malaria encompass a 
wide range of disease syndrome, from uncomplicated 
malaria to severe life-threatening forms of malaria. Cer-
ebral malaria (CM) is a potentially fatal form of malaria 
caused by the human malaria parasite Plasmodium 
falciparum, which causes the death of several thousand 
children per year in sub-Saharan Africa [1]. Not all indi-
viduals infected with P. falciparum succumb to severe 
malaria and only about 1–2 % of infected hosts succumb 
to the cerebral form of the disease [2, 3]. With the advent 
of current anti-malarial treatments, the chances of sur-
vival of CM cases have increased substantially, but it is 
observed that survivors may suffer from long-term neu-
rological deficits [1, 4]. Historically, the presence of para-
sites in comatose patients in malaria-endemic areas was 
considered adequate reason for the administration of 
anti-malarials. The diagnosis of CM is difficult because 
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coma could be a consequence of a variety of neurologi-
cal syndromes. Often autopsy results would conclusively 
diagnose the disease, by which time it is too late for 
the patient. Beyond coma and other non-specific neu-
rological symptoms, perhaps retinopathy is the only 
advancement that has become one of the best diagnos-
tic indicators of CM [5]. The causes of CM are broadly 
ascribed to inflammation, sequestration and vascular 
blockage, leading to hypoxia and hypoglycaemia, result-
ing in complex neurological sequelae [6]. The susceptibil-
ity of an individual to a severe form of malaria, especially 
that of CM, has been the subject of study over several 
decades, so that such pathology may be prevented. How-
ever, as of now, no reliable predictor(s), clinical or molec-
ular, are known that would be prognostic of CM at an 
early time point (pre-clinical or uncomplicated stages) in 
a malaria-infected individual. There is a need to develop 
tools and techniques that may provide an early indication 
of the susceptibility to the cerebral stage of the disease. 
Observations on human CM are possible only in post-
mortem tissues, and at best in the cerebro-spinal fluids, 
but a longitudinal study is not feasible. Amongst animal 
models, the best available is the murine model, which 
may have certain limitations, but nevertheless exhib-
its a range of similarities, including perturbations in the 
integrity of the blood–brain barrier, infected red blood 
cell (RBC) sequestration to the cerebral microvascula-
ture, microvascular damage, and generation of cognitive 
impairments [7–9].
The difficulties of a longitudinal study in humans are 
complicated by the genetic diversity of hosts and para-
sites, as are variation in the environment, and metabolic 
and physiological parameters. The cumulative incidence 
of CM is variable in mice. It ranges from 50 to 100 % [10]. 
In this laboratory setting, the partitioning of the C57Bl/6 
mice infected with Plasmodium berghei ANKA strain 
into CM and non-cerebral malaria (NCM) is nearly 50 % 
[11] and this allowed the addressal of metabolic suscepti-
bility not only within the same genotypes, but also within 
the same batch of animals. Clinical features, such as rec-
tal temperature, the clinical manifestations of CM, such 
as ataxia, paralysis, coma, and convulsions, and a differ-
ential survival rate, makes the final classification of the 
disease into two definite classes of CM and NCM mice 
possible [11]. However, these CM symptoms are observ-
able only at the late stages of the disease while in the 
early stages the animals are physiologically indistinguish-
able. Thus, it becomes possible to follow the same animal 
cohort as they move into two distinct groups and deter-
mine the metabolic differences.
CM-susceptible mice have been compared with NCM 
mice at the late stage of the disease [12–14]. The dif-
ference in the metabolic pathways in CM and NCM in 
various tissues and biofluids were delineated [13]. How-
ever, information and understanding of the early meta-
bolic changes are lacking. Moreover, the methods that 
can predict CM are limited. The SmithKline Beecham, 
Harwell, Imperial College, Royal London Hospital, phe-
notype assessment (SHIRPA) protocol relates behavioural 
aspects of the mice to death [15, 16]. The method involves 
40 independent parameters to be looked at simultane-
ously, which is difficult to apply in a high-throughput 
study. Furthermore, the strategy is difficult to translate 
to humans because the tests are specific to rodents. The 
chemokines, CXCL4 and CXCL10 levels also predict the 
risk of CM in human [17]. This prediction is, however, 
based on data collected from patients who have already 
succumbed to CM. Similarly, malaria score for adults 
(MSA) predicts deaths in adults but this is again based on 
parameters of patients after they succumbed to the dis-
ease [18]. In another study, papilloedema and extramacu-
lar retinal oedema were used to predict death in CM [19]. 
These cases were also the advanced stages of CM. It has 
been shown that the angiopoietin 1 and 2 were associ-
ated with CM. However, even in this study the patients 
had already succumbed to the disease [20]. Thus, there is 
no reliable predictor of the disease at an early time point.
With the advent of ‘metabolomics’ [21], it is possible 
to build predictive models of metabolites that would dis-
criminate CM from NCM during the sub-clinical stages. 
Metabolomics is a hypothesis-free study, which can be 
used to assay the observable metabolites in biofluids/tis-
sue, develop temporal trajectories of the metabolites, and 
thus follow the disease progression and identify meta-
bolic marker/s for specific stages of the disease. One of 
the objectives of this investigation was to identify early 
metabolic signature(s) of CM, using serum samples. 
In this paper the results of these investigations are pre-
sented. The results suggest that serum lipids/lipoproteins 
levels may represent early indicators of the onset of CM 
in both male and female animals. Temporal tracking of 
the CM and NCM animals showed that serum lipid/lipo-
protein levels are higher in CM with respect to NCM in 
early days of infection.
Methods
Animals used for the study
The animals were treated in accordance with the guide-
lines set forth by the Institutional Animal Ethics Com-
mittee of TIFR (IAEC approval no: TIFR/IAEC/2010-3). 
The mice used for the study were C57Bl/6 of 6–8 weeks 
and weighing 20–25  g. They were maintained in 12  h 
light and dark cycle at 22 ± 2 °C and had free access to 
water and standard food pellets. Initially, four separate 
experiments for female mice were performed with 20 
mice in each experiment (Fig. 1). Blood was withdrawn 
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from animals on different days post-infection (pi): day 1, 
day 2, day 3, and day 4 pi, in four separate experiments 
with different sets of mice, respectively. These experi-
ments were done to understand the maximal difference 
in CM and NCM animals before symptoms of the dis-
ease are evident. Since the results show a maximal dif-
ference in the metabolic profile of serum in day 4 pi, the 
experiment for day 4 pi was repeated where the blood 
was withdrawn only at day 4 pi from a new set of ani-
mals. A separate experiment was conducted with a 
group of male mice to unravel sexual dimorphism in 
the molecular marker/s of CM. Yet another independ-
ent experiment was carried out to compare the meta-
bolic profiles and to understand the sequence of events 
in the animals with CM/NCM. In order to understand 
the disease progression in CM versus NCM, mice were 
bled at day 3, 4 and 5 pi and the two groups of animals 
were compared in one experimental set-up. However, 
the mice used to compare the metabolic profile at day 3, 
4 and 5 pi were different to avoid stress in mice due to 
consecutive daily bleeding.
Inoculation of mice, disease progression and assessment
In each of the four experiments, five mice were used as 
uninfected controls. The remaining animals were injected 
intraperitoneally with 107 RBCs infected with P. berghei 
ANKA  [22]. Rectal temperature of the mice was meas-
ured daily using a digital thermometer. The infected ani-
mals were monitored for the neurological symptoms of 
CM from day 5 pi. Mice were considered to have CM if 
they had rectal temperature <34  °C accompanied with 
neurological symptoms such as ataxia, convulsions and 
coma. The NCM mice, on the other hand, exhibited 
no neurological symptoms and had body temperature 
>34 °C. At day 8/9 pi the symptoms of CM were clearly 
visible in addition to the reduced rectal temperature 
which helped in categorizing the mice into CM and 
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Fig. 1 The scheme of retro-orbital bleeding from the group of mice in a set of different experiments. The down arrows refer to the early time point 
in which mice were bled. A Scheme for retro-orbital bleeding in different experiments. B Typical 700 MHz 1H NMR spectrum of serum of a control 
C57Bl/6. 1 Lipids [1a –CH3, 1b –(CH2)n–, 1c –CH2CH2CO, 1d –CH2C=C, 1e –CH2=CO–, 1f =C–(CH2)–C=], 2 leucine, 3 isoleucine, 4 valine, 5 lactate, 6 
alanine, 7 acetate, 8 glutamine, 9 glutamate, 10 methionine, 11 acetate, 12 citrate, 13 lysine, 14 creatine, 15 choline, 16 phosphocholine, 17 GPC, 18 
glucose
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NCM was unambiguous. Some of the mice died during 
the night and some had borderline rectal temperature 
at day 9 pi. These were excluded from the study. Blood 
(100  µl) was collected by retro-orbital bleeding from 
the mice at indicated time points pi in the four schemes 
(Fig. 1). The assignment of the sample (blood) to CM and 
NCM mice at an earlier time point is based on the dis-
eased state of the mice at day 9 pi.
Sample preparation for 1H nuclear magnetic resonance 
(NMR) of sera
The blood samples were incubated at 37  °C for 10  min, 
centrifuged for 10  min at 13,100g at 4  °C. Supernatant 
was collected, frozen immediately in liquid N2 and stored 
at −80  °C until the nuclear magnetic resonance (NMR) 
experiment. For NMR experiments, 60 µl of sample was 
mixed with 500 µL of buffer (0.075  M Na2HPO4·7H2O, 
4  % NaN3, 0.02  % TSP, pH 7.4). The buffer recipe was 
provided by Bruker Biospin, Metabonomic unit, Rhein-
stetten, Germany.
1H NMR of sera
1H NMR spectra at 310  K was acquired on AVANCE 
III 700 MHz Bruker spectrometer with triple resonance 
inverse probe using D2O (10  % of the sample volume) 
as the field-frequency lock. The samples were placed 
in 5-mm NMR tubes. The pulse sequence used for the 
experiment was of the form—RD-90°-(τ-180-τ-)n-90°-
ACQ. Relaxation delay (RD) of 4  s was used between 
consecutive transients. Water signal was suppressed 
by continuous irradiation using low power pulse dur-
ing RD. Car–Purcell–Meiboom–Gill (CPMG) spin echo 
block (τ-180-τ-)n with a loop count (n) of 128 was used 
to attenuate the broad signals from the macromolecules. 
Echo time for the experiment (τ) was 300  µs. In these 
experiments 32 transients were collected into 88,640 data 
points using a spectral width of 20.06 ppm. The 90° pulse 
lengths were individually determined for all the samples. 
The free induction decays were subjected to exponen-
tial multiplication leading to an additional line broaden-
ing of 1 Hz, a Gaussian multiplication of 0.01 Hz, and a 
sine-squared, bell apodization function prior to Fourier 
transformation. The resulting spectra were phased and 
baseline corrected by the automation programs pro-
vided by Bruker Biospin. The assignments of metabolites 
were based on 2D-COSY, 2D-(1H–1H) TOCSY and 2D 
J-resolved spectroscopy experiments. The assignment 
was further aided using Human Metabolome Database 
(HMDB) [23] and also cross-checked from literature [24]. 
For COSY and TOCSY experiments, 64 transients per 
increment and 256 increments were collected in the indi-
rect dimension. A QSINE function with 2048 and 1024 
digital points was used for processing. An exponential 
multiplication of 0.20 and 0.30 Hz in the direct and indi-
rect dimension was used, respectively. TOCSY was pro-
cessed using sine function. An exponential multiplication 
of 0.20 and 0.30 Hz in the direct and indirect dimension 
was used, respectively. In addition, a Gaussian multipli-
cation of 0.1  Hz in the indirect dimension was applied 
for the TOCSY. 2D J-resolved spectra were also recorded 
to aid the assignments of the metabolites. The pulse 
sequence is of the form—RD-90-t1-180-t1-ACQ. The RD 
was 2 s and the number of scans being one for all experi-
ments. The number of data points in direct and indirect 
dimension was 16k and 256, respectively. The spectral 
widths in direct and indirect dimensions were 16.63 ppm 
and 0.15 Hz ppm, respectively. After the Fourier transfor-
mation, baseline correction was performed followed by 
45° tilt of the spectrum.
Data pre‑processing and statistical analysis
The spectral region of 0.5–4.2 ppm is bucketed into fre-
quency windows of 0.003 ppm and was normalized with 
respect to the working region. The region corresponding 
to water (4.5–5.5  ppm) was excluded during binning to 
avoid artefacts due to water pre-saturation. The region 
corresponding to aromatic regions was also excluded 
because it had poor signal to noise ratio compared to the 
aliphatic region. All the binning and normalizations are 
performed in AMIX 2.0 (Bruker Biospin). The resulting 
matrix was imported in SIMCA P+ 12.0 (Umetrics AB, 
Malmo, Sweden) for multivariate analysis.
Principal component analysis (PCA) and orthogonal partial 
least square discriminant analysis (OPLS‑DA)
The 2D data matrix obtained after normalization is sub-
jected to PCA analysis. PCA was done to look into trend 
of the data and to check if there were outliers. This was 
followed by OPLS/OPLS-DA [25]. OPLS-DA gives segre-
gation between two classes along predictive component. 
The R2X and Q2Y are the two parameters that judge the 
model. While the former explains the total explained var-
iation in the data, the latter is a cross-validation param-
eter that explains the predictive power of the model. 
One-seventh of the data are excluded in each cross-val-
idation round. The metabolites that are responsible for 
segregation are represented by OPLS-DA coefficients 
plots [26]. The plots are generated using GNUPLOT.
Results
Early metabolic markers in serum for CM
The scheme for blood collection from mice in differ-
ent experiments is depicted in Fig.  1A. The 1H NMR 
of serum of an uninfected control mouse was assigned 
using COSY and is shown in Fig. 1B. All the discriminant 
analyses involving CM and NCM at days 1–5 were based 
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on their physiological status at days 8–9 pi. The OPLS-
DA models of the 1H NMR spectra of the sera samples 
of CM and NCM have poor segregation on day 1 and day 
2 pi (Table 1). On day 3 pi, the segregation between the 
classes increases compared to day 1 and day 2 pi as is evi-
dent from the increased value of Q2Y of the correspond-
ing OPLS-DA model. On day 4 pi, further improvement 
in segregation between CM and NCM was evident from 
the high Q2Y value (Fig.  2A; Table  1). The molecules 
that contribute to the segregation are glucose, moie-
ties of lipids and lipoproteins, such as –CH3, –(CH2)n–, 
–CH2CH2CO, –CH2C=C, –CH2C=O, =C–(CH2)–C= 
(Fig. 2B). The OPLS-DA coefficient plot (Fig. 2B) clearly 
suggests that lipids/lipoproteins concentrations are high 
in CM, while that of glucose is low. In addition, glycer-
ophosphocholine (GPC) is high in NCM sera. The unsu-
pervised PCA model was also able to segregate CM and 
NCM at day 4 pi (Additional file 1). Further separate sta-
tistical models were built with individual infected groups 
and controls. It was evident from such models that 
lipids are increased in the CM and decreased in NCM 
with respect to the controls (Fig. 2C–F). The predictive 
metabolite markers of CM and the robustness of such 
markers on day 4 pi were further investigated in another 
experiment which included a group of male and female 
mice. As seen in Table 1 and in Fig. 3A, the segregation 
of the 1H NMR profile of CM and the NCM are distinct. 
This distinction is due to the presence of a high con-
centration of serum lipids/lipoproteins in CM (Fig. 3B). 
Glucose is not involved in the segregation of CM and 
NCM. In order to make analysis independent of the 
terminal time point, a separate analysis was performed 
where the bins corresponding to lipids were denoted as 
the ‘response variables’. Thus, a separate OPLS model for 
day 4 pi was created to see if the groups segregate solely 
on the basis of lipids (1.54–1.62, 2.81–2.73, 2.24–2.31, 
1.92–2.07, 0.82–0.89, 1.23–1.30  ppm). It is seen that in 
the case of the first experiment there are two mis-clas-
sifications of CM and in the second case there is mis-
classification of one CM with a prediction rate of 71 and 
83.3 % (Additional file 2a, b). In order to know whether 
the molecules contributing towards the segregation are 
the same in the other sex, 1H NMR spectrum of NCM 
and CM male mice were compared on day 4 pi with the 
help of multivariate statistics. It is clear (Fig.  3C) that 
the two groups of animals are indeed distinct and that 
serum lipids/lipoproteins are responsible for the seg-
regation (Fig.  3D). Also, as in the case of the females, 
glucose appeared to have no significant contribution 
towards segregation (Fig.  3D). Moreover, when each of 
the infected class was compared with the controls it was 
found that lipids/lipoproteins increased in concentration 
in the serum of mice with CM while it is decreased in 
NCM (Additional file 3).  
Temporal tracking of CM and NCM mice
An important aspect of this study was to compare the 
metabolic profiles of animals with NCM and CM as 
the disease progresses. This is expected to provide use-
ful information about the evolving metabolic status of 
the host. The results of the experiments mentioned so 
far involved collection of serum in separate sets of ani-
mals, of different batches, injected with parasites at 
different times of the year. A direct comparison of the 
profiles of the same set of mice with NCM/CM was 
not possible. Therefore, an independent experiment 
was set up to accomplish this. The parasitemia profile 
and survival is shown in Additional file  4. Serum sam-
ples were drawn on days 2, 3, 4, and 5 pi (Fig.  1), and 
PCA analysis of 1H NMR spectra for CM and NCM 
mice was performed. The analysis shows that at day 4 pi 
the CM mice form a separate clustering with respect to 
NCM (Additional file  5). This is followed by OPLS-DA 
analysis. The statistical models were created for NCM 
and CM (Table 2). The results clearly show that day 3 pi 
onwards, the serum profiles of NCM were distinct from 
CM (Fig. 4A–C). Serum lipids/lipoproteins significantly 
contribute towards segregation (Fig. 4D–F) and remain 
consistently high in CM sera compared to the NCM dur-
ing the pre-clinical stage. The number of serum lipid/
lipoprotein peaks increase in CM mice with respect to 
NCM mice as the disease progresses. The OPLS-DA 
models created for infected groups (CM/NCM) versus 
control are shown in Additional file 6a–c. In comparison 
to the uninfected control the serum lipoprotein is higher 
in CM on days 3–5 pi. The enhancement ranges from 
14 ± 0.02 to 19 ± 0.09 % at day 4 pi in three independ-
ent experiments. A cut-off of fold change of 14 % of total 
lipoproteins in serum predicts 54–71 % CM. The change 
in the level of lipids in CM at day 4 pi is presented in 
(Additional file 7) for all the experiments. A ROC curve 
was plotted with the cross-validated ‘Y’ variables for the 
OPLS-DA plots created at day 4 pi (Additional file  8). 
Table 1 Parameters of  the OPLS-DA models created 
with 1H NMR profile of sera of CM and NCM for the scheme 
given in Fig. 1 and the repeat experiments
CM versus NCM R2Y Q2Y
Day 1 female 0.27 0.00
Day 2 female 0.39 0.14
Day 3 female 0.72 0.44
Day 4 female 0.84 0.70
Day 4 female (repeat) 0.87 0.54
Day 4 male 0.90 0.61
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The area under curve of the ROC plots are 1, 0.95 and 1, 
respectively, for day 4 pi of experiments 4, 5 and 6 of CM 
and NCM mice.
Discussion
This study reports on the possible early molecular sig-
natures that distinguish mice susceptible to CM ver-
sus those that are not, in the murine CM model of P. 
berghei ANKA parasite and C57Bl/6 mice. The earliest 
that the mice can be distinctly clustered is day 3 or 4 pi, 
the latter day being more robust (Q2 > 0.5). Mice with 
CM could be distinguished from NCM and control on 
the basis of higher levels of serum lipids/lipoproteins. 
Earlier, it has been established that at day 8–9 pi there 
is an increase in lipids/lipoproteins in the sera of CM 
mice [13]. It is now apparent that such increase starts 
from day 3 pi. This observation was robust and was 
seen in male mice as well. Thus, a 14–19 % increase of 
serum lipids/lipoproteins could be used as a marker for 
CM in mice. These results are obtained from a murine 
model of the disease wherein well-established mouse 
and parasite strains have been used, and the experi-
ment including the number of parasites injected and 
the housing of animals are all tightly controlled. It 
should be noted that the distinction of CM from NCM 



























































































Fig. 2 Pairwise OPLS-DA scores and coefficients plot of 1H NMR spectra of serum of CM, NCM and control at day 4 post-infection in experiment 
4. A OPLS-DA scores plot of CM and NCM at day 4 post infection, B OPLS-DA coefficient plot of A, C OPLS-DA scores plot of NCM and control, D 
OPLS-DA coefficient plot of C, E OPLS-DA scores plot CM and control, F OPLS-DA coefficient plot of E. The red, black and blue symbols denote CM, 
NCM and control, respectively. The ellipse in the scores plot is a 95 % Hotelling T2. The colour bar indicates the correlation of the metabolites in the 
segregation between two concerned classes
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obtained here is robust not only in females but in the 
case of males as well.
It would be interesting to see if the change in lipids/
lipoproteins observed here is robust enough to be seen in 
a field situation of human malaria. Since humans exhibit 
large variations in terms of age, ethnicity, lifestyles, etc., 
this might involve screening of large (entire) popula-
tions to arrive at the basal levels of circulating lipids/
lipoproteins.
The temporal tracking throws light on the alterations in 
the host. It is important to note that serum glucose does 
not appear to play any discriminatory role in CM versus 
NCM at days 3–4 pi although on day 5 enhanced level 
of glucose is observed in NCM sera compared to CM. 
Moreover, serum lactate does not contribute significantly 
towards segregation of CM and NCM during this period. 
Thus, glycolysis, its substrate glucose and the end product 
lactate are not involved in differentiating CM and NCM 
animals at an earlier stage of infection but later time 
points and glucose levels indeed seem to be perturbed 
in CM in comparison with NCM. The possible forma-
tion of triglycerides from glucose at day 8–9 pi in CM has 
already been reported. In this study it seems that such a 
perturbation is operative from day 5 pi. The negative cor-
relation of blood glucose and triglycerides in OPLS-DA 
plot at day 5 pi is suggestive of such perturbation.
Phospholipids are an important class of lipids which 
are required by the parasite during proliferation [27], are 
used for metabolic co-factor and membrane formation 
and affect host physiology [28, 29]. A sixfold increase in 
the phospholipids in the infected erythrocytes has been 
reported [30]. Parasites scavenge fatty acids from the host 
cells and serum, modify them by elongases and desatu-

























































3.5 2.02.53.0 1.5 1.0 0.54.0
Fig. 3 OPLS-DA scores and coefficient plot of CM and NCM at day 4 post infection for experiment 5. A OPLSDA scores plot of CM and NCM for 
female mice, B OPLS-DA coefficient plot of A, C OPLSDA scores plot of CM and NCM for male mice, D OPLS-DA coefficient plot of C. The red and 
black symbols denote CM and NCM, respectively. The ellipse in the scores plot is a 95 % Hotelling T2. The colour bar indicates the correlation of the 
metabolites in the segregation between two concerned classes
Table 2 Parameters of  the OPLS-DA models created 
with 1H NMR profile of sera of CM and NCM for the scheme 
given in Additional file 3
NCM versus CM R2Y Q2Y
Day 2 0.00 0.00
Day 3 0.70 0.37
Day 4 0.87 0.62
Day 5 0.88 0.77
Page 8 of 10Ghosh et al. Malar J  (2016) 15:198 
[31]. Thus, lipids of the host are channelized to various 
pathways in the parasites for their survival. The parasites 
can uptake host fatty acids [32, 33] and lipoproteins [34]. 
In cultured P. falciparum, large quantities of lipids are 
taken up during trophozoite and early schizont stages 
[35]. This parasite-mediated uptake of lipids/lipopro-
teins could alter the host-circulating homeostasis, which 
in turn could affect the level of lipids/lipoproteins in the 
host serum. One of the characteristics of CM is seques-
tration of parasites [36] and increase in the levels of TNF 
[37]. Both these parameters have an effect on the lipid 
metabolism, which might cause an elevation in the levels 
of lipids/lipoproteins, specifically in CM. All three steps 
of lipid metabolism, i.e., fatty acid uptake, lipogenesis and 
lipolysis, are perturbed by extracellular stimuli, such as 
cytokines [38]. It is important to note that in some stud-
ies administration of TNF increases the lipolysis pathway 
and leads to increased concentration of free fatty acids 
in vivo and in vitro [38]. It is also important to note that 
TNF is known to cause a decrease in the expression of 
transporter of free fatty acid. Therefore, it may decrease 
free fatty acid uptake and induce hyperlipidaemia [38].
The parasites have the machinery for fatty acid synthe-
sis (FAS II pathway). However, this pathway is not abso-
lutely essential for the parasites in the blood stages [39]. 
Although FAS II appears to be non-essential in the blood 
stage of the parasites, in some patients infected with 
Plasmodium an upregulation of FAS II genes has been 
reported [40]. A detailed analysis in this respect is nec-
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Fig. 4 OPLS-DA scores and co-efficient plot of CM and NCM at different day post infection for experiment 6. A Scores plot of CM and NCM at day 3 
post infection, B OPLS-DA coefficient plot of A, C scores plot of CM and NCM at day 4 post infection, D OPLS-DA coefficient plot of C, E scores plot 
of CM and NCM at day 5 post infection, F OPLS-DA coefficient plot of E. The red and black symbols denote CM and NCM, respectively. The ellipse in 
the scores plot is a 95 % Hotelling T2. The colour bar indicates the correlation of the metabolites in the segregation between two concerned classes
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disequilibrium. In parasite extracts, hydroxyl derivatives 
of polyenoic fatty acids were found although they lack 
lipoxygenase enzyme, which is required for the formation 
of hydroxy fatty acids. Alternatively, hydroxy fatty acids 
could be generated by haem catabolism. Hydroxyacids 
play an inhibitory role in the monocyte function and 
hence mediate the host immune response. Lipid metabo-
lism in parasites could therefore be an important part in 
host-parasite lipid balance [41]. Lipid metabolism is thus 
crucial, in many ways, for the survival of the parasite. It 
is also clear (Fig. 4) that as the disease progresses a num-
ber of peaks corresponding to lipids/lipoproteins appear 
in CM. This may be used as a qualitative identifier of CM 
in mice. The specific role of lipids in CM needs further 
investigation.
The changes in the lipid levels documented in this 
study are quantitative. The exact nature of enhanced 
lipids could not be resolved through these experiments. 
Quantitative mass spectrometric analysis may reveal 
specific lipid/phospholipid change in the CM mice. 
However, a threshold level may be able to be worked 
out for general lipid levels. In these studies, such a level 
fixation of fold change greater than 14 % can predict cor-
rectly the susceptibility for CM in about 54–71 % of the 
mice, independent of the sex of the animal. It may be 
possible to set such a threshold of lipids to predict sus-
ceptibility to CM versus other severity in malaria. This 
study can serve as a beginning for further investigation 
into the risk factors, mechanisms, vaccines, adjunct 
treatments for CM in the mouse model before the dis-
ease pathology sets in. It is proposed that the differ-
ences in serum lipids/lipoproteins of human patients be 
assessed so that a profile could be used as effective prog-
nostic marker(s) of CM.
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